Home Coronavirus
Coronavirus
Investors cannot afford to ignore a GP set that has largely outperformed industry benchmarks, even during a pandemic.
Top executives from Campbell Lutyens, Evercore, Lazard and PJT Partners shared their views for Kirkland & Ellis's liquidity masterclass this week.
The secondaries market is where big changes in private equity will occur, says Hamilton Lane’s long-time chief executive.
Business that have benefited from the coronavirus crisis are as difficult to value as those that have suffered, says Glendower Capital's CIO at the annual BVCA Summit.
We look under the hood of what drove the Australian SWF to undertake a major rebalancing of its private equity portfolio prior to the coronavirus pandemic.
RCP Advisors was targeting a summer final close for its $150m overage fund, which will invest alongside its flagship secondaries fund in coronavirus-induced opportunities.
Kempen Capital Management’s director, private markets, Marvin de Jong, warns that the covid-19 crisis is not a re-run of 2008.
For better or worse private equity fundraising will have to be conducted with less of a human touch.
We catch up with investment bank Evercore's private capital advisory head, who discusses single-asset transactions, secondaries deals in the era of covid-19 and what's in store for the market this year.
Strategies that worked well for buyers during the bull market may no longer work, says the investment firm's head of secondaries Jeff Akers.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: